These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 745806)

  • 41. [The behavior of the fibrinogen polymerization curve in hypercholesterolemic subjects].
    Alessandri C; Bucci A; Basili S; Pacillo L; Ricci G
    Clin Ter; 1993 Feb; 142(2):115-21. PubMed ID: 8472524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Incidence of reduced fibrinolytic activity and fibrinogen increase in the pathogenesis of vascular risk in obese subjects. Study of fibrinolytic activity of plasma, fibrinogen, erythrocyte aggregation and plasma viscosity].
    Craveri A; Tornaghi G; Paganardi L; Ranieri R; di Bella M
    Minerva Cardioangiol; 1988 Nov; 36(11):563-7. PubMed ID: 3244424
    [No Abstract]   [Full Text] [Related]  

  • 43. Fibrinogenemia, determined immunonephelometrically, as a possible parameter in the evaluation of peripheral arteriosclerotic arteriopathy.
    Pola P; Savi L
    Atherosclerosis; 1978 Feb; 29(2):205-16. PubMed ID: 646850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Selected biochemical components of plasma and blood viscosity in patients with arteriosclerosis].
    Turczyński B; Znamirowska D; Szczesny S; Grzegorczyn S
    Pol Arch Med Wewn; 1987 Jun; 77(6):300-5. PubMed ID: 3271281
    [No Abstract]   [Full Text] [Related]  

  • 45. Increased platelet and coagulatory activity in peripheral atherosclerosis flow mediated platelet function is a sensitive and specific disease indicator.
    Reininger CB; Graf J; Reininger AJ; Spannagl M; Steckmeier B; Schweiberer L
    Int Angiol; 1996 Dec; 15(4):335-43. PubMed ID: 9127775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Changes in viscosity of reduced serum in patients with atherosclerosis].
    Turczyński B; Sroczyński J; Kossmann S
    Pol Tyg Lek; 1976 Oct; 31(43):1829-32. PubMed ID: 981013
    [No Abstract]   [Full Text] [Related]  

  • 47. Abnormal plasma and serum viscosity in systemic lupus erythematosus (SLE): a Jamaican study.
    Reid HL; De Ceulaer K
    Clin Hemorheol Microcirc; 1999; 20(3):175-80. PubMed ID: 10463841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent].
    Freyberger H; Schifferdecker E; Schatz H
    Med Klin (Munich); 1994 Nov; 89(11):594-7, 633. PubMed ID: 7815987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on blood viscosity during the menstrual cycle and in the postmenopausal period in healthy women.
    Larsson H; Persson S; Hedner P; Odeberg H; Gustafson A
    Acta Obstet Gynecol Scand; 1989; 68(6):483-6. PubMed ID: 2520801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on pharmacological enhancement of blood fibrinolytic activity.
    Gormsen J; Laursen B
    Angiology; 1970 Sep; 21(8):546-51. PubMed ID: 4990278
    [No Abstract]   [Full Text] [Related]  

  • 51. [Prescriptions for arteriosclerosis therapy].
    Fanelli Y
    Clin Ter; 1978 Mar; 84(6):641-7. PubMed ID: 648110
    [No Abstract]   [Full Text] [Related]  

  • 52. Influence of Arwin on the flow properties of blood.
    Ehrly AM
    Biorheology; 1973 Sep; 10(3):453-6. PubMed ID: 4772016
    [No Abstract]   [Full Text] [Related]  

  • 53. A report on the use of Arvin in patients with pre-gangrene of the lower limb.
    Humphreys WV; Walker A; Charlesworth D
    Br J Surg; 1977 Jan; 64(1):31-3. PubMed ID: 831951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prevention and therapy of lesions of the blood vessel wall].
    Mörl H
    Med Klin; 1978 May; 73(19):722-9. PubMed ID: 349333
    [No Abstract]   [Full Text] [Related]  

  • 55. Haematological stress syndrome in atherosclerosis.
    Stuart J; George AJ; Davies AJ; Aukland A; Hurlow RA
    J Clin Pathol; 1981 May; 34(5):464-7. PubMed ID: 7251888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use and monitoring of antithrombotic drug therapy. The need for a new approach.
    Fletcher AP; Alkjaersig N
    Thromb Haemost; 1977 Dec; 38(4):881-92. PubMed ID: 579693
    [No Abstract]   [Full Text] [Related]  

  • 57. Quantitative studies on the relationship of fibrinogen and "fibrin" in intima and atherosclerotic plaque.
    York JL; Benjamin W
    Thromb Res; 1980 Jun; 18(5):717-24. PubMed ID: 7414557
    [No Abstract]   [Full Text] [Related]  

  • 58. Relationship between fibrinogen and blood viscosity.
    Matsuda T; Murakami M
    Thromb Res; 1976 May; 8(2 suppl):25-33. PubMed ID: 936079
    [No Abstract]   [Full Text] [Related]  

  • 59. [On fibrinogen in atherosclerosis and hypertension].
    Atanasov K
    Folia Med (Plovdiv); 1967; 9(5):270-4. PubMed ID: 4972391
    [No Abstract]   [Full Text] [Related]  

  • 60. [Fibrinolytic activity. Its importance in atherosclerosis].
    Brochier M
    Sem Ther; 1965 May; 41(5):297-8. PubMed ID: 4228304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.